Global Sertraline Market Research Report 2021
Table of Contents1 Sertraline Market Overview
1.1 Product Overview and Scope of Sertraline
1.2 Sertraline Segment by Type
1.2.1 Global Sertraline Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Tablet
1.2.3 Oral Concentrate
1.3 Sertraline Segment by Application
1.3.1 Sertraline Sales Comparison by Application: (2021-2027)
1.3.2 Adult
1.3.3 Children
1.4 Global Sertraline Market Size Estimates and Forecasts
1.4.1 Global Sertraline Revenue 2016-2027
1.4.2 Global Sertraline Sales 2016-2027
1.4.3 Sertraline Market Size by Region: 2016 Versus 2021 Versus 2027
2 Sertraline Market Competition by Manufacturers
2.1 Global Sertraline Sales Market Share by Manufacturers (2016-2021)
2.2 Global Sertraline Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Sertraline Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Sertraline Manufacturing Sites, Area Served, Product Type
2.5 Sertraline Market Competitive Situation and Trends
2.5.1 Sertraline Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Sertraline Players Market Share by Revenue
2.5.3 Global Sertraline Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Sertraline Retrospective Market Scenario by Region
3.1 Global Sertraline Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Sertraline Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Sertraline Market Facts & Figures by Country
3.3.1 North America Sertraline Sales by Country
3.3.2 North America Sertraline Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Sertraline Market Facts & Figures by Country
3.4.1 Europe Sertraline Sales by Country
3.4.2 Europe Sertraline Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Sertraline Market Facts & Figures by Region
3.5.1 Asia Pacific Sertraline Sales by Region
3.5.2 Asia Pacific Sertraline Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Sertraline Market Facts & Figures by Country
3.6.1 Latin America Sertraline Sales by Country
3.6.2 Latin America Sertraline Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Sertraline Market Facts & Figures by Country
3.7.1 Middle East and Africa Sertraline Sales by Country
3.7.2 Middle East and Africa Sertraline Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Sertraline Historic Market Analysis by Type
4.1 Global Sertraline Sales Market Share by Type (2016-2021)
4.2 Global Sertraline Revenue Market Share by Type (2016-2021)
4.3 Global Sertraline Price by Type (2016-2021)
5 Global Sertraline Historic Market Analysis by Application
5.1 Global Sertraline Sales Market Share by Application (2016-2021)
5.2 Global Sertraline Revenue Market Share by Application (2016-2021)
5.3 Global Sertraline Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Sertraline Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Pfizer Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Teva
6.2.1 Teva Corporation Information
6.2.2 Teva Description and Business Overview
6.2.3 Teva Sertraline Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Teva Product Portfolio
6.2.5 Teva Recent Developments/Updates
6.3 Mylan
6.3.1 Mylan Corporation Information
6.3.2 Mylan Description and Business Overview
6.3.3 Mylan Sertraline Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Mylan Product Portfolio
6.3.5 Mylan Recent Developments/Updates
6.4 APOTEX
6.4.1 APOTEX Corporation Information
6.4.2 APOTEX Description and Business Overview
6.4.3 APOTEX Sertraline Sales, Revenue and Gross Margin (2016-2021)
6.4.4 APOTEX Product Portfolio
6.4.5 APOTEX Recent Developments/Updates
6.5 Aurobindo Pharma
6.5.1 Aurobindo Pharma Corporation Information
6.5.2 Aurobindo Pharma Description and Business Overview
6.5.3 Aurobindo Pharma Sertraline Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Aurobindo Pharma Product Portfolio
6.5.5 Aurobindo Pharma Recent Developments/Updates
6.6 Lupin Pharmaceuticals
6.6.1 Lupin Pharmaceuticals Corporation Information
6.6.2 Lupin Pharmaceuticals Description and Business Overview
6.6.3 Lupin Pharmaceuticals Sertraline Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Lupin Pharmaceuticals Product Portfolio
6.6.5 Lupin Pharmaceuticals Recent Developments/Updates
6.7 Torrent Pharmaceuticals
6.6.1 Torrent Pharmaceuticals Corporation Information
6.6.2 Torrent Pharmaceuticals Description and Business Overview
6.6.3 Torrent Pharmaceuticals Sertraline Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Torrent Pharmaceuticals Product Portfolio
6.7.5 Torrent Pharmaceuticals Recent Developments/Updates
6.8 Sun Pharmaceutical
6.8.1 Sun Pharmaceutical Corporation Information
6.8.2 Sun Pharmaceutical Description and Business Overview
6.8.3 Sun Pharmaceutical Sertraline Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Sun Pharmaceutical Product Portfolio
6.8.5 Sun Pharmaceutical Recent Developments/Updates
6.9 Oxford Pharma
6.9.1 Oxford Pharma Corporation Information
6.9.2 Oxford Pharma Description and Business Overview
6.9.3 Oxford Pharma Sertraline Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Oxford Pharma Product Portfolio
6.9.5 Oxford Pharma Recent Developments/Updates
7 Sertraline Manufacturing Cost Analysis
7.1 Sertraline Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Sertraline
7.4 Sertraline Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Sertraline Distributors List
8.3 Sertraline Customers
9 Sertraline Market Dynamics
9.1 Sertraline Industry Trends
9.2 Sertraline Growth Drivers
9.3 Sertraline Market Challenges
9.4 Sertraline Market Restraints
10 Global Market Forecast
10.1 Sertraline Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Sertraline by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Sertraline by Type (2022-2027)
10.2 Sertraline Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Sertraline by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Sertraline by Application (2022-2027)
10.3 Sertraline Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Sertraline by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Sertraline by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of TablesTable 1. Global Sertraline Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Sertraline Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Sertraline Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Sertraline Covered in This Study
Table 5. Global Sertraline Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Sertraline Sales Share by Manufacturers (2016-2021)
Table 7. Global Sertraline Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Sertraline Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Sertraline Average Price (USD/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Sertraline Manufacturing Sites and Area Served
Table 11. Manufacturers Sertraline Product Type
Table 12. Global Sertraline Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Sertraline by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sertraline as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Sertraline Sales by Region (2016-2021) & (K Units)
Table 16. Global Sertraline Sales Market Share by Region (2016-2021)
Table 17. Global Sertraline Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Sertraline Sales by Country (2016-2021) & (K Units)
Table 19. North America Sertraline Sales Market Share by Country (2016-2021)
Table 20. North America Sertraline Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Sertraline Revenue Market Share by Country (2016-2021)
Table 22. Europe Sertraline Sales by Country (2016-2021) & (K Units)
Table 23. Europe Sertraline Sales Market Share by Country (2016-2021)
Table 24. Europe Sertraline Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Sertraline Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Sertraline Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Sertraline Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Sertraline Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Sertraline Revenue Market Share by Region (2016-2021)
Table 30. Latin America Sertraline Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Sertraline Sales Market Share by Country (2016-2021)
Table 32. Latin America Sertraline Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Sertraline Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Sertraline Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Sertraline Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Sertraline Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Sertraline Revenue Market Share by Country (2016-2021)
Table 38. Global Sertraline Sales (K Units) by Type (2016-2021)
Table 39. Global Sertraline Sales Market Share by Type (2016-2021)
Table 40. Global Sertraline Revenue (Million US$) by Type (2016-2021)
Table 41. Global Sertraline Revenue Share by Type (2016-2021)
Table 42. Global Sertraline Price (USD/Unit) by Type (2016-2021)
Table 43. Global Sertraline Sales (K Units) by Application (2016-2021)
Table 44. Global Sertraline Sales Market Share by Application (2016-2021)
Table 45. Global Sertraline Revenue (Million US$) by Application (2016-2021)
Table 46. Global Sertraline Revenue Share by Application (2016-2021)
Table 47. Global Sertraline Price (USD/Unit) by Application (2016-2021)
Table 48. Pfizer Corporation Information
Table 49. Pfizer Description and Business Overview
Table 50. Pfizer Sertraline Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 51. Pfizer Sertraline Product
Table 52. Pfizer Recent Developments/Updates
Table 53. Teva Corporation Information
Table 54. Teva Description and Business Overview
Table 55. Teva Sertraline Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 56. Teva Sertraline Product
Table 57. Teva Recent Developments/Updates
Table 58. Mylan Corporation Information
Table 59. Mylan Description and Business Overview
Table 60. Mylan Sertraline Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 61. Mylan Sertraline Product
Table 62. Mylan Recent Developments/Updates
Table 63. APOTEX Corporation Information
Table 64. APOTEX Description and Business Overview
Table 65. APOTEX Sertraline Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 66. APOTEX Sertraline Product
Table 67. APOTEX Recent Developments/Updates
Table 68. Aurobindo Pharma Corporation Information
Table 69. Aurobindo Pharma Description and Business Overview
Table 70. Aurobindo Pharma Sertraline Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 71. Aurobindo Pharma Sertraline Product
Table 72. Aurobindo Pharma Recent Developments/Updates
Table 73. Lupin Pharmaceuticals Corporation Information
Table 74. Lupin Pharmaceuticals Description and Business Overview
Table 75. Lupin Pharmaceuticals Sertraline Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 76. Lupin Pharmaceuticals Sertraline Product
Table 77. Lupin Pharmaceuticals Recent Developments/Updates
Table 78. Torrent Pharmaceuticals Corporation Information
Table 79. Torrent Pharmaceuticals Description and Business Overview
Table 80. Torrent Pharmaceuticals Sertraline Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 81. Torrent Pharmaceuticals Sertraline Product
Table 82. Torrent Pharmaceuticals Recent Developments/Updates
Table 83. Sun Pharmaceutical Corporation Information
Table 84. Sun Pharmaceutical Description and Business Overview
Table 85. Sun Pharmaceutical Sertraline Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 86. Sun Pharmaceutical Sertraline Product
Table 87. Sun Pharmaceutical Recent Developments/Updates
Table 88. Oxford Pharma Corporation Information
Table 89. Oxford Pharma Description and Business Overview
Table 90. Oxford Pharma Sertraline Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 91. Oxford Pharma Sertraline Product
Table 92. Oxford Pharma Recent Developments/Updates
Table 93. Production Base and Market Concentration Rate of Raw Material
Table 94. Key Suppliers of Raw Materials
Table 95. Sertraline Distributors List
Table 96. Sertraline Customers List
Table 97. Sertraline Market Trends
Table 98. Sertraline Growth Drivers
Table 99. Sertraline Market Restraints
Table 100. Global Sertraline Sales Forecast by Type (2022-2027) & (K Units)
Table 101. Global Sertraline Sales Market Share Forecast by Type (2022-2027)
Table 102. Global Sertraline Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 103. Global Sertraline Revenue Market Share Forecast by Type (2022-2027)
Table 104. Global Sertraline Sales Forecast by Application (2022-2027) & (K Units)
Table 105. Global Sertraline Sales Market Share Forecast by Application (2022-2027)
Table 106. Global Sertraline Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 107. Global Sertraline Revenue Market Share Forecast by Application (2022-2027)
Table 108. Global Sertraline Sales Forecast by Region (2022-2027) & (K Units)
Table 109. Global Sertraline Sales Market Share Forecast by Region (2022-2027)
Table 110. Global Sertraline Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 111. Global Sertraline Revenue Market Share Forecast by Region (2022-2027)
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of FiguresFigure 1. Product Picture of Sertraline
Figure 2. Global Sertraline Market Share by Type in 2020 & 2027
Figure 3. Tablet Product Picture
Figure 4. Oral Concentrate Product Picture
Figure 5. Global Sertraline Market Share by Application in 2020 & 2027
Figure 6. Adult
Figure 7. Children
Figure 8. Global Sertraline Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 9. Global Sertraline Market Size 2016-2027 (US$ Million)
Figure 10. Global Sertraline Sales 2016-2027 (K Units)
Figure 11. Global Sertraline Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 12. Sertraline Sales Share by Manufacturers in 2020
Figure 13. Global Sertraline Revenue Share by Manufacturers in 2020
Figure 14. The Global 5 and 10 Largest Sertraline Players: Market Share by Revenue in 2020
Figure 15. Sertraline Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 16. Global Sertraline Sales Market Share by Region (2016-2021)
Figure 17. Global Sertraline Sales Market Share by Region in 2020
Figure 18. Global Sertraline Revenue Market Share by Region (2016-2021)
Figure 19. Global Sertraline Revenue Market Share by Region in 2020
Figure 20. U.S. Sertraline Revenue Growth Rate (2016-2021) (US$ Million)
Figure 21. Canada Sertraline Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Germany Sertraline Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. France Sertraline Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. U.K. Sertraline Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Italy Sertraline Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Russia Sertraline Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. China Sertraline Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Japan Sertraline Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. South Korea Sertraline Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. India Sertraline Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Australia Sertraline Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Taiwan Sertraline Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Indonesia Sertraline Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Thailand Sertraline Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Malaysia Sertraline Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Philippines Sertraline Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Vietnam Sertraline Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Mexico Sertraline Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Brazil Sertraline Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Argentina Sertraline Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Turkey Sertraline Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Saudi Arabia Sertraline Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. U.A.E Sertraline Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Sales Market Share of Sertraline by Type (2016-2021)
Figure 45. Sales Market Share of Sertraline by Application (2016-2021)
Figure 46. Sales Market Share of Sertraline by Application in 2020
Figure 47. Revenue Share of Sertraline by Application (2016-2021)
Figure 48. Revenue Share of Sertraline by Application in 2020
Figure 49. Manufacturing Cost Structure of Sertraline
Figure 50. Manufacturing Process Analysis of Sertraline
Figure 51. Sertraline Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed